Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.

MUC1 mucin is a large complex glycoprotein expressed on normal epithelial cells in humans and overexpressed and under or aberrantly glycosylated on many malignant cancer cells which consequently allows recognition of the protein core by antibodies. In order to understand how glycosylation may modulate or regulate antibody binding of mucin protein core epitopes, we have analyzed the antibody C595 (epitope RPAP) for its structure, stability, and its binding to a series of synthetic peptides and glycopeptides by a number of spectroscopic methods. Thermal and pH denaturation studies followed by changes in the CD spectrum of the antibody indicate critical involvement of specific residues to the stability of the antibody. Fluorescence binding studies indicate that alpha-N-acetylgalactosamine (GalNAc) glycosylation of a MUC1 mucin synthetic peptide TAPPAHGVT9SAPDTRPAPGS20T21APPA at threonine residues 9 and 21 and serine residue 20 enhanced the binding of antibody. The structural effects of GalNAc glycosylation on the conformation of the MUC1 peptide were studied. CD of the peptides and glycopeptides in a cryogenic mixture cooled to approximately -97 degrees C revealed that a left-handed polyproline II helix (PPII) is adopted by the peptides in solution, which appears to be further stabilized by addition of the GalNAc residues. Consistent with the PPII helical structure, which has no intra-amide hydrogen bonds, high-field NMR spectroscopy of the glycopeptide revealed no sequential dNN, medium-range, or long-range nuclear Overhauser effect (NOE) connectivities. These studies indicate that stabilization of the PPII helix by GalNAc glycosylation present the epitope of C595 antibody with a favorable conformation for binding. Furthermore, they illustrate that glycosylation of the MUC1 tumor marker protein with a simple O-linked saccharide expressed in many cancers, can enhance the binding of the clinically relevant C595 antibody.

[1]  A. Drake,et al.  Analysis of the architecture of the transcription factor σN (σ54) and its domains by circular dichroism , 1997, Molecular microbiology.

[2]  E. Giralt,et al.  Convergent Synthesis of Repeating Peptides (Val-X-Leu-Pro-Pro-Pro)(8) Adopting a Polyproline II Conformation. , 1996, The Journal of organic chemistry.

[3]  T. Terada,et al.  Expression of mucin carbohydrate antigens (T, Tn and sialyl Tn) and MUC-1 gene product in intraductal papillary-mucinous neoplasm of the pancreas. , 1996, American journal of clinical pathology.

[4]  M. Price,et al.  Effect of glycosylation of a synthetic MUC1 mucin-core-related peptide on recognition by anti-mucin antibodies. , 1996, Cancer letters.

[5]  Lin Ds,et al.  Circular dichroism spectroscopy of monoclonal antibodies that bind a superpotent guanidinium sweetener ligand. , 1996 .

[6]  A. Drake,et al.  The importance of extended conformations and, in particular, the PII conformation for the molecular recognition of peptides , 1995, Biopolymers.

[7]  S. Gendler,et al.  The epithelial mucin, MUC1, of milk, mammary gland and other tissues. , 1995, Biochimica et biophysica acta.

[8]  J. Fontenot,et al.  Structure of a tumor associated antigen containing a tandemly repeated immunodominant epitope. , 1995, Journal of biomolecular structure & dynamics.

[9]  I. Brockhausen,et al.  Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. , 1995, European journal of biochemistry.

[10]  F. Hanisch,et al.  Studies on the order and site specificity of GalNAc transfer to MUC1 tandem repeats by UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase from milk or mammary carcinoma cells. , 1995, European journal of biochemistry.

[11]  M. Meldal,et al.  Comparison of N-Dts and N-Aloc in the solid-phase syntheses of O-GlcNAc glycopeptide fragments of RNA-polymerase II and mammalian neurofilaments , 1995 .

[12]  G. Springer.  T and Tn pancarcinoma markers: autoantigenic adhesion molecules in pathogenesis, prebiopsy carcinoma-detection, and long-term breast carcinoma immunotherapy. , 1995, Critical reviews in oncogenesis.

[13]  J. Ramshaw,et al.  Electrostatic interactions in collagen-like triple-helical peptides. , 1994, Biochemistry.

[14]  M. Meldal,et al.  Attachment of oligosaccharides to peptide antigen profoundly affects binding to major histocompatibility complex class II molecules and peptide immunogenicity , 1994, European journal of immunology.

[15]  Y. Kim,et al.  Immunohistochemical study of mucin carbohydrates and core proteins in human ovarian tumors. , 1994, Human pathology.

[16]  M. Price,et al.  Immune recognition of human colonic‐tumour‐associated muc‐2 mucins using an anti‐peptide antibody , 1993, International journal of cancer.

[17]  W. Mantulin,et al.  Comparative circular dichroism studies of an anti-fluorescein monoclonal antibody (Mab 4-4-20) and its derivatives. , 1992, Biochemistry.

[18]  Y. Inoue,et al.  N.m.r. study of interaction between sugar and peptide moieties in mucin-type model glycopeptides. , 1992, International journal of biological macromolecules.

[19]  L. Otvos,et al.  Chemical glycosylation of peptide T at natural and artificial glycosylation sites stabilizes or rearranges the dominant reverse turn structure. , 1992, Biochemical and biophysical research communications.

[20]  M. Price,et al.  Monoclonal antibody binding to peptide epitopes conjugated to synthetic branched chain polypeptide carriers. Influence of the carrier upon antibody recognition. , 1992, Journal of immunological methods.

[21]  H. Mantsch,et al.  Glycosylation of synthetic peptides breaks helices. Phosphorylation results in distorted structure. , 2009, International journal of peptide and protein research.

[22]  N. Peat,et al.  Structure and biology of a carcinoma-associated mucin, MUC1. , 1991, The American review of respiratory disease.

[23]  R. W. Baldwin,et al.  C595--a monoclonal antibody against the protein core of human urinary epithelial mucin commonly expressed in breast carcinomas. , 1990, British Journal of Cancer.

[24]  Y. Inoue,et al.  N.m.r. study on conformation of Ac-Thr(alpha-GalNAc)-Ala-Ala-OMe as a model for mucin type glycoprotein. , 2009, International journal of peptide and protein research.

[25]  Y. Kim,et al.  Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. , 1989, Cancer research.

[26]  J. Rothbard,et al.  A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. , 1988, The Journal of biological chemistry.

[27]  A. Drake,et al.  Reassessment of the electronic circular dichroism criteria for random coil conformations of poly(L-lysine) and the implications for protein folding and denaturation studies. , 1988, Biophysical chemistry.

[28]  K. Carraway,et al.  Mechanism of expression of Thomsen‐Friedenreich (T) antigen at the cell surface of a mammary adenocarcinoma , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  W C Johnson,et al.  Variable selection method improves the prediction of protein secondary structure from circular dichroism spectra. , 1987, Analytical biochemistry.

[30]  W C Johnson,et al.  Analysis of protein circular dichroism spectra for secondary structure using a simple matrix multiplication. , 1986, Analytical biochemistry.

[31]  N. Helbecque,et al.  Critical chain length for polyproline-II structure formation in H-Gly-(Pro)n-OH. , 2009, International journal of peptide and protein research.

[32]  Johnson Wc,et al.  Information content in the circular dichroism of proteins. , 1981 .

[33]  J. Jensenius,et al.  The binding of anti‐immunoglobulin antibodies to rat thymocytes and thoracic duct lymphocytes , 1974, European journal of immunology.

[34]  C. L. Schmidt,et al.  THE SOLUBILITIES, APPARENT DISSOCIATION CONSTANTS, AND THERMODYNAMIC DATA OF THE DIHALOGENATED TYROSINE COMPOUNDS , 1935, The Journal of general physiology.

[35]  J. Greenstein.  STUDIES OF THE PEPTIDES OF TRIVALENT AMINO ACIDS I. TITRATION CONSTANTS OF HISTIDYL-HISTIDINE AND OF ASPARTYL-ASPARTIC ACID , 1931 .

[36]  H. S. Simms.  THE NATURE OF THE IONIZABLE GROUPS IN PROTEINS , 1928, The Journal of general physiology.